Skip links and keyboard navigation


What is haemovigilance?

Haemovigilance is a set of surveillance procedures covering the whole transfusion chain (from the collection of blood and its components to the follow-up of recipients), intended to collect and assess information or unexpected or undesirable effects resulting from the therapeutic use of blood products, and to prevent their occurrence or recurrence.

Queensland's approach to haemovigilance

Under National Safety and Quality Health Service Standard 7 - Blood and Blood Products (Standard 7), health service organisations are required to ensure that blood and blood product adverse events are included in the incidents management and investigation system including by:

  • having blood and blood product incidents reported to and reviewed by the highest level of governance in the health service organisation, and
  • participating in haemovigilance activities conducted by the organisation or at state or national levels

Local haemovigilance activities may include:

  • Completing the electronic haemovigilance form in response to blood related incidents reported in local incident monitoring systems
  • reviewing and validating the haemovigilance data in the form
  • exporting the haemovigilance data from the form into a master spreadsheet for local record keeping and reporting purposes
  • providing de-identified haemovigilance data for national haemovigilance reports

The Department of Health’s role in haemovigilance is to:

Recommended actions for Queensland hospitals and health facilities

It is recommended that hospitals and health facilities:

  • consider and follow the guideline on haemovigilance data collection, validation and reporting
  • use the electronic haemovigilance form to collect data on the adverse event. The forms are available from
  • seek independent validation of the reported event information
  • use the available Haemovigilance Coordinator Master Record to import the data from the electronic form, once the information has been validated.  This process is generally managed by the hospital transfusion nurse/haemovigilance coordinator/quality officer. The Master Record is available by email at
  • when requested, provide the de-identified data in the spreadsheet to the Department of Health for inclusion in national reporting. 

National haemovigilance reports

National Blood Authority Australia Haemovigilance Reporting 

Last updated: 28 November 2016

Governance and committees

The Queensland Department of Health meets the responsibilities of the National Blood Agreement through membership on the Jurisdictional Blood Committee.

The department is also informed by the Queensland Blood Advisory Council, the Queensland Blood Advisory Council and the Transfusion Laboratory Advisory Committee. Secretariat services are provided by Queensland Health'sMedicine Complianceand Human Tissue Unit.